Items | NSCLC patients (N = 265) |
---|---|
Age (years) | |
Mean ± SD | 62.0 ± 10.6 |
Median (IQR) | 62.0 (55.0–68.0) |
Sex, No. (%) | |
Male | 205 (77.4) |
Female | 60 (22.6) |
History of smoke, No. (%) | 150 (56.6) |
History of drink, No. (%) | 103 (38.9) |
Hypertension, No. (%) | 95 (35.8) |
Hyperlipidemia, No. (%) | 87 (32.8) |
Diabetes, No. (%) | 44 (16.6) |
Pathological grade, No. (%) | |
G1 | 44 (16.6) |
G2 | 160 (60.4) |
G3 | 61 (23.0) |
Tumor size (cm) | |
Mean ± SD | 5.3 ± 2.1 |
Median (IQR) | 5.0 (4.0–7.0) |
LYN metastasis, No. (%) | 93 (35.1) |
TNM stage, No. (%) | |
I | 86 (32.5) |
II | 90 (34.0) |
III | 89 (33.5) |
CEA (ng/mL) | |
Mean ± SD | 47.7 ± 172.8 |
Median (IQR) | 6.2 (2.9–27.6) |